Checkpoint Systems, Inc. Company Profile

17:33 EDT 18th March 2019 | BioPortfolio

Checkpoint Systems is a global leader in merchandise availability solutions for the retail industry, encompassing loss prevention and merchandise visibility. Checkpoint provides end-to-end solutions enabling retailers to achieve accurate real-time inventory, accelerate the replenishment cycle, prevent out-of-stocks and reduce theft, thus improving merchandise availability and the shopper’s experience. Checkpoint's solutions are built upon 45 years of radio frequency technology expertise, innovative high-theft and loss-prevention solutions, market-leading RFID hardware, software, and comprehensive labeling capabilities to brand, secure and track merchandise from source to shelf. Checkpoint's customers benefit from increased sales and profits by implementing merchandise availability solutions to ensure the right merchandise is available at the right place and time when consumers are ready to buy. Listed on the NYSE (NYSE: CKP), Checkpoint operates in every major geographic market and employs more than 4700 people worldwide.

News Articles [788 Associated News Articles listed on BioPortfolio]

New findings may help oncologists determine effectiveness of checkpoint inhibitors

In a study published in JCI Insight, researchers have identified checkpoint inhibitor resistance mechanisms in many solid tumour cancers, including melanoma, lung cancer and breast cancer.  Checkpoi...

Can CytomX’s Probody checkpoint beat the competition?

We have increasingly seen how oncologists like the efficacy associated with the immune checkpoint combination of ipilimumab plus nivolumab, but…

How many PD-1 and PD-L1 checkpoint inhibitors do we need?

STUTTGART, Germany I June 19, 2018 I La Merie Publishing released the results of an independent search for and evaluation of PD-1 and PD-L1 immune checkpoint inhibitors in preclinical and clinical dev...

Checkpoint Inhibitors Driving the Immunotherapy Market

The multibillion-dollar immunotherapy market is expected to experience further growth on advancements in checkpoint inhibitor biotechnology. The post Checkpoint Inhibitors Driving the Immunotherapy Ma...

Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors

This Medical News article discusses the evolution of checkpoint inhibitor immunotherapies to improve efficacy and predict which patients will benefit the most.

Enthusiasm for checkpoint inhibitor combination trials shows no sign of abating

Combinations involving checkpoint therapies are starting to be used as the standard of care in certain metastatic cancer types, such...Read More... The post Enthusiasm for checkpoint inhibitor combina...

Checkpoint Therapeutics’ Share Price Dips on Preliminary Results

Although Checkpoint Therapeutic’s (NASDAQ:CKPT) released preliminary results of its clinical trial on Thursday (September 6), investors are not sharing the enthusiasm. The post Checkpoint Therapeuti...

BMS, Compugen Pursue Multiple Checkpoint Inhibitions In Antibody Collaboration

Bristol-Myers Squibb is teaming up with Compugen to test the latter’s investigational antibody that targets a new checkpoint, PVRIG, in...   

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Oxygen compressed gas [dallas life support systems inc]


Anticoagulant citrate dextrose a acd-a [arteriocyte medical systems, inc.]

Anticoagulant Citrate Dextrose Solution,Solution A, USP

Oxygen [biomedics systems, inc.]


Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

PubMed Articles [1222 Associated PubMed Articles listed on BioPortfolio]

Implications of alternative routes to APC/C inhibition by the mitotic checkpoint complex.

The mitotic checkpoint (also called spindle assembly checkpoint) is a signaling pathway that ensures faithful chromosome segregation. Mitotic checkpoint proteins inhibit the anaphase-promoting complex...

Psychophysiological and Specific Fine Motor Skill Modifications in a Checkpoint Action.

In last years, the insurgency attacks on task forces bases and checkpoints have been common. The study of psychophysiological response of soldiers in these asymmetrical and non-controlled situations r...

Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma.

The ligation of PD-1 with PD-L1 activates a critical immune checkpoint leading to T cell dysfunction, exhaustion, and tolerance. Anti-PD-1 or anti-PD-L1 monoclonal antibodies can reverse the immune ch...

Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.

Immune checkpoint inhibitors-based immunotherapy offers a new effective modality in the treatment of advanced malignancies. Considering the remarkable efficacy of immune checkpoint inhibitors in clini...

Screening responsive or resistant biomarkers of immune checkpoint inhibitors based on online databases.

Immune checkpoint inhibitors are a promising strategy in the treatment of cancer, especially advanced types. However, not all patients are responsive to immune checkpoint inhibitors. The response rate...

Clinical Trials [1413 Associated Clinical Trials listed on BioPortfolio]

Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases

The tolerance of immune checkpoint inhibitors is unknown in patients with pre-existing autoimmune conditions. This retrospective nation-wide study will assess their tolerance in patients w...

Perioperative Chemo and Pembrolizumab in Gastric Cancer

The purpose of this study is to determine the effectiveness of combining immune checkpoint blockade therapy with standard chemotherapy. People who usually have this are treated with 3 cycl...

Autoantibodies in Treatment With Immune Checkpoint Inhibitors (AUTENTIC)

The aim of this study is to assess the effectiveness of a battery of autoantibodies to predict the occurrence of immune-related adverse events (irAEs) in patients with cancer who will be t...

Resistance to Immunotherapy in Gastric Cancer

This project seeks to analyze and define the mechanism (s) involved in the resistance to checkpoint therapy in metastatic GC patients. The investigators propose the use of a Next-Generatio...

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

The investigators hypothesize that vorolanib in combination with checkpoint inhibitors (pembrolizumab for gastric/gastroesophageal (GE) junction cancers and nivolumab for hepatocellular ca...

Companies [1391 Associated Companies listed on BioPortfolio]

Checkpoint Systems, Inc.

Checkpoint Systems is a global leader in merchandise availability solutions for the retail industry, encompassing loss prevention and merchandise visibility. Checkpoint provides e...

Checkpoint Surgical, Inc.

Checkpoint Surgical is a privately held, Cleveland, Ohio based medical device company committed to providing surgeons with user-friendly, cost-effective devices to protect and rep...

Checkpoint Systems

FLX Bio, Inc.

FLX475 is a best-in-class oral, small molecule antagonist of CCR4. CCR4 ligands are elevated in multiple tumor types when compared to normal tissue. In preclinical studies, FLX475...

Agenus, Inc.

Agenus is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants. Agenus’ checkpoint modulator programs ...

More Information about "Checkpoint Systems, Inc." on BioPortfolio

We have published hundreds of Checkpoint Systems, Inc. news stories on BioPortfolio along with dozens of Checkpoint Systems, Inc. Clinical Trials and PubMed Articles about Checkpoint Systems, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Checkpoint Systems, Inc. Companies in our database. You can also find out about relevant Checkpoint Systems, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record